{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:24:15Z","timestamp":1768537455726,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.micpath.2023.105968","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T16:26:14Z","timestamp":1673108774000},"page":"105968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Microbiota and hepatitis C virus in the era of direct-acting antiviral agents"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-5434","authenticated-orcid":false,"given":"Biagio","family":"Pinchera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Schiano","family":"Moriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Riccardo","family":"Buonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Zappulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Viceconte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Villari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.micpath.2023.105968_bib1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.micpath.2023.105968_bib2","first-page":"8","article-title":"Ome sweet \u2018omics - a genealogical treasury of words","volume":"15","author":"Lederberg","year":"2001","journal-title":"Scientist"},{"issue":"9","key":"10.1016\/j.micpath.2023.105968_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection","volume":"11","author":"Preveden","year":"2017","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.micpath.2023.105968_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00431-014-2476-2","article-title":"The intestinal microbiota: its role in health and disease","volume":"174","author":"Biedermann","year":"2015","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.micpath.2023.105968_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.dld.2015.07.008","article-title":"The human gut microbiota and virome: potential therapeutic implications","volume":"47","author":"Scarpellini","year":"2015","journal-title":"Dig. Liver Dis."},{"issue":"7402","key":"10.1016\/j.micpath.2023.105968_bib6","first-page":"7","article-title":"A framework for human micro- biome research","volume":"486","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.micpath.2023.105968_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrg3182","article-title":"The human microbiome: at the interface of health and disease","volume":"13","author":"Cho","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.micpath.2023.105968_bib8","first-page":"285","article-title":"The influence of the gut microbiota on host physiology: in pursuit of mechanisms","volume":"89","author":"Jones","year":"2016","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3920\/BM2012.0065","article-title":"Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics","volume":"5","author":"Geurts","year":"2014","journal-title":"Benef. Microbes"},{"issue":"4","key":"10.1016\/j.micpath.2023.105968_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/microorganisms3040759","article-title":"Gut microbiota and host reaction in liver diseases","volume":"3","author":"Fukui","year":"2015","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2023.105968_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3389\/fmicb.2015.00918","article-title":"The human gut virome: a multifaceted majority","volume":"6","author":"Ogilvie","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2023.105968_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/326032","article-title":"Gut inflammation and immunity: what is the role of the human gut virome?","volume":"2015","author":"Foc\u00e0","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bpg.2016.02.004","article-title":"Barritt AS 4th. Intestinal microbiota in liver disease","volume":"30","author":"Haque","year":"2016","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.micpath.2023.105968_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1574887111666160810100538","article-title":"Gut microbiota and alcoholic liver disease","volume":"11","author":"Scarpellini","year":"2016","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.micpath.2023.105968_bib15","article-title":"EASL recommendation on treatment of hepatitis C 2018","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib16","first-page":"26","article-title":"Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy","volume":"41","author":"Buonomo","year":"2018","journal-title":"New Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2023.105968_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1071\/SH17168","article-title":"Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: results from a prospective study","volume":"15","author":"Gentile","year":"2018","journal-title":"Sex. Health"},{"key":"10.1016\/j.micpath.2023.105968_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.micpath.2023.105968_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/137.3.781S","article-title":"Cross-talk between probiotic bacteria and the host immune system","volume":"137","author":"Corth\u00e9sy","year":"2007","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13099-022-00501-4","article-title":"Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load","volume":"14","author":"Ashour","year":"2022","journal-title":"Gut Pathog."},{"issue":"10","key":"10.1016\/j.micpath.2023.105968_bib21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/nu10101457","article-title":"Gut microbiota's relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics","volume":"10","author":"Meng","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib22","first-page":"1","article-title":"Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia","volume":"7","author":"Xue","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.micpath.2023.105968_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5897\/AJMR2018.9028","article-title":"Lactobacillus acidophilus and Bifidobacteria spp. having antibacterial and antiviral effects on chronic HCV infection","volume":"13","author":"Allam","year":"2019","journal-title":"Afr. J. Microbiol. Res."},{"key":"10.1016\/j.micpath.2023.105968_bib24","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3389\/fimmu.2018.01318","article-title":"Preventive effect of a synbiotic combination of galacto-and fructooligosaccharides mixture with Bifidobacterium breve M-16V in a model of multiple rotavirus infections","volume":"9","author":"Rigo-Adrover","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2023.105968_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5411\/wji.v4.i2.52","article-title":"Gut immune response in the presence of hepatitis C virus infection","volume":"4","author":"Hetta","year":"2014","journal-title":"World J. Immunol."},{"key":"10.1016\/j.micpath.2023.105968_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","article-title":"Gut microbiome alterations in patients with stage 4 hepatitis C","volume":"8","author":"Aly","year":"2016","journal-title":"Gut Pathog."},{"issue":"2","key":"10.1016\/j.micpath.2023.105968_bib28","doi-asserted-by":"crossref","first-page":"e00300","DOI":"10.1128\/mBio.00300-15","article-title":"Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii","volume":"6","author":"Miquel","year":"2015","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.micpath.2023.105968_bib29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/apt.13732","article-title":"HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients","volume":"44","author":"Bajaj","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2023.105968_bib30","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellularcarcinoma: epidemiologyand molecular carcinogenesis","volume":"132","author":"El-SeragHB","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2023.105968_bib31","first-page":"399","article-title":"Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection","volume":"vol. 29","author":"Gentile","year":"2015","journal-title":"In Vivo"},{"key":"10.1016\/j.micpath.2023.105968_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijid.2017.07.026","article-title":"Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis","volume":"63","author":"Buonomo","year":"2017","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/biology10010055","article-title":"Changes of gut-microbiota-liver Axis in hepatitis C virus infection","volume":"10","author":"El-Mowafy","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.micpath.2023.105968_bib34","first-page":"91","article-title":"Evaluation of bacterial translocation in patients with chronic HCV infection","volume":"52","author":"Munteanu","year":"2014","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.micpath.2023.105968_bib35","first-page":"50","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.micpath.2023.105968_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105739","article-title":"Structural and compositional segregation of the gut microbiota in HCV and liver cirrhotic patients: a clinical pilot study","volume":"171","author":"Ullah","year":"2022","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/liv.15041","article-title":"Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection","volume":"42","author":"Inoue","year":"2022","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.micpath.2023.105968_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/jhep.2003.50116","article-title":"Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats","volume":"37","author":"Lorenzo-Z\u00fa\u00f1iga","year":"2003","journal-title":"Hepatol."},{"issue":"5","key":"10.1016\/j.micpath.2023.105968_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microb."},{"key":"10.1016\/j.micpath.2023.105968_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0016-5085(19)33602-9","article-title":"Bile acid inhibition ofthe intestinal microflora\u2014a function for simple bile acids","volume":"61","author":"Floch","year":"1971","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2023.105968_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000198872","article-title":"Hepatic secretion of bilirubin and biliary lipids in patientswith alcoholic cirrhosis of the liver","volume":"26","author":"Raedsch","year":"1983","journal-title":"Digestion"},{"key":"10.1016\/j.micpath.2023.105968_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(84)92109-3","article-title":"The leaky gut of alcoholism: possibleroute of entry for toxic compounds","volume":"1","author":"Bjornason","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2023.105968_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/jgs.16206","article-title":"Efficacy of direct-acting antivirals for chronic hepatitis C in a large cohort of older adults in the United States","volume":"68","author":"Pan","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.micpath.2023.105968_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","article-title":"Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction","volume":"5","author":"Geddawy","year":"2017","journal-title":"J. Translat. Int. Med."},{"issue":"5","key":"10.1016\/j.micpath.2023.105968_bib45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40620-019-00608-z","article-title":"Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection","volume":"32","author":"Coppola","year":"2019","journal-title":"J. Nephrol."},{"issue":"2","key":"10.1016\/j.micpath.2023.105968_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11739-019-02163-8","article-title":"Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study","volume":"15","author":"Di Minno","year":"2020","journal-title":"Int. Emerg. Med."},{"key":"10.1016\/j.micpath.2023.105968_bib47","first-page":"jiab094","article-title":"Improvement of gut diversity and composition after direct-acting antivirals in HCV-infected patients with or without HIV coinfection","author":"Chuaypen","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.31700","article-title":"Eradication of chronic HCV infection: improvement of dysbiosis only in patients without liver cirrhosis","volume":"74","author":"Wellh\u00f6ner","year":"2021","journal-title":"Hepatol."},{"key":"10.1016\/j.micpath.2023.105968_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000371678","article-title":"Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut","volume":"33","author":"Ridlon","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.micpath.2023.105968_bib50","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2023.105968_bib51","article-title":"Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C","author":"Huang","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib52","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41598-022-09534-w","article-title":"Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents","volume":"12","author":"Hsu","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2023.105968_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03009-0","article-title":"Changes in the gut microbiota after hepatitis C virus eradication","volume":"11","author":"Honda","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.micpath.2023.105968_bib54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/ph14090931","article-title":"Pilot sub-study of the effect of hepatitis C cure by glecaprevir\/pibrentasvir on the gut microbiome of patients with chronic hepatitis C genotypes 1 to 6 in the mythen study","volume":"14","author":"Yilmaz","year":"2021","journal-title":"Pharmaceuticals"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:29:34Z","timestamp":1736404174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":54,"alternative-id":["S0882401023000013"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.105968","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota and hepatitis C virus in the era of direct-acting antiviral agents","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.105968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105968"}}